European Medicines Agency: * EMA: EMA’S EMERGENCY TASK FORCE ADVISES ON INTRADERMAL USE OF IMVANEX / JYNNEOS AGAINST MONKEYPOX : 19/08/2022
* EMA: ETF CAUTIONED HIGHER RISK OF LOCAL REACTIONS (E.G. LONGER-LASTING REDNESS, THICKENING OR DISCOLORATION OF SKIN) AFTER INTRADERMAL INJECTIONS * EMA: NATIONAL AUTHORITIES MAY DECIDE TO USE IMVANEX TEMPORARILY AS INTRADERMAL INJECTION AT LOWER DOSE TO PROTECT AT-RISK INDIVIDUALS
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
The IRS has increased IRA contribution limits for 2026. Savers can contribute up to $7,500,…
June 2026 will feature the FIFA World Cup kickoff, the U.S. Open at Shinnecock Hills,…
Rumors about a new $2,000 stimulus check are spreading online, but no federal payment has…
Learn how to activate Epix Now on Roku, Firestick, Apple TV and Smart TVs using…
Robo advisors offer low-cost automated investing while financial advisors provide personal guidance for complex money…
Learn how to activate Gaia on Roku, Apple TV, FireStick, and Android TV with simple…